Mostrar o rexistro simple do ítem
Mechanism of Action of Streptococcus downii, a New Bacterial Species with Probiotic Potential
dc.contributor.author | Martínez Lamas, Lucía | * |
dc.contributor.author | García-Mato, E. | * |
dc.contributor.author | Rincón Quintero, Anniris Maria | * |
dc.contributor.author | Rivas-Mundiña, B. | * |
dc.contributor.author | Diz Dios, Pedro | * |
dc.contributor.author | Alvarez Fernández, Maximiliano | * |
dc.date.accessioned | 2025-09-10T08:43:57Z | |
dc.date.available | 2025-09-10T08:43:57Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Martínez-Lamas L, García-Mato E, Rincón-Quintero A, Rivas-Mundiña B, Diz-Dios P, Álvarez-Fernández M. Mechanism of Action of Streptococcus downii, a New Bacterial Species with Probiotic Potential. Antibiotics. 2023;12(9). | |
dc.identifier.issn | 2079-6382 | |
dc.identifier.other | https://portalcientifico.sergas.gal//documentos/6522c80aec1a10197ffd986a | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/21730 | |
dc.description.abstract | Streptococcus downii is a recently reported bacterial species of oral origin, with inhibitory capacity against Streptococcus mutans, Actinomyces naeslundii, Veillonella parvula and Aggregatibacter actinomycetemcomitans, which confers upon it the potential of being an oral probiotic. The aim of the present study was to identify the potential mechanisms by which S. downii exerts its inhibitory effect on S. mutans. To this end, the study assessed the consumption of glucose and proteins available in the culture medium, the modification of the pH, the production of short-chain fatty acids, the changes in the protein panel of the inhibition halo, the production of hydrogen peroxide and the effect of proteinase K. There were no differences in the glucose values or in the protein content of the medium, but there was a reduction in pH (with no effect on the growth of S. mutans). Significant increases were detected in the levels of lactic and formic acid (with no effect on the growth of S. mutans), as well as changes in the peptide panel (with no effect on the growth of S. mutans). The inhibitory effect was maintained in the presence of peroxidase but disappeared after adding proteinase K. Based on these results, it is suggested that the main mechanism of inhibition of S. downii against S. mutans is the production of bacteriocins. | |
dc.description.sponsorship | This research was funded by project IN855A-2016/36 financed by the Xunta de Galicia under the Resolution of the Galician Innovation Agency of 12 August 2016 (Ignicia Program); project I4TRANSF financed by the Galician Agency for Knowledge Management in Health (PRIS3 Program); project 00-00002474-16 financed by the Foundation for Innovation and Foresight in Health in Spain (FIPSE); and project DTS22/00056 funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. | |
dc.language | eng | |
dc.rights | Attribution 4.0 International (CC BY 4.0) | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Mechanism of Action of Streptococcus downii, a New Bacterial Species with Probiotic Potential | |
dc.type | Artigo | |
dc.authorsophos | Martínez-Lamas, L.; García-Mato, E.; Rincón-Quintero, A.; Rivas-Mundiña, B.; Diz-Dios, P.; Álvarez-Fernández, M. | |
dc.identifier.doi | 10.3390/antibiotics12091472 | |
dc.identifier.sophos | 6522c80aec1a10197ffd986a | |
dc.issue.number | 9 | |
dc.journal.title | Antibiotics | * |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)::Microbioloxía | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Vigo::Microbioloxía | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Atención Primaria Santiago::Odontoloxía e estomatoloxía | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Vigo::Microbioloxía | |
dc.relation.projectID | Xunta de Galicia under the Resolution of the Galician Innovation Agency of 12 August 2016 (Ignicia Program) [IN855A-2016/36] | |
dc.relation.projectID | Galician Agency for Knowledge Management in Health (PRIS3 Program) [I4TRANSF] | |
dc.relation.projectID | Foundation for Innovation and Foresight in Health in Spain (FIPSE) [00-00002474-16] | |
dc.relation.projectID | Instituto de Salud Carlos III (ISCIII) [DTS22/00056] | |
dc.relation.projectID | European Union | |
dc.relation.publisherversion | https://doi.org/10.3390/antibiotics12091472 | |
dc.rights.accessRights | openAccess | * |
dc.subject.keyword | AS Santiago | |
dc.subject.keyword | IDIS | |
dc.subject.keyword | AS Vigo | |
dc.subject.keyword | CHUVI | |
dc.subject.keyword | AS Santiago | |
dc.subject.keyword | AS Santiago AP | |
dc.subject.keyword | AS Vigo | |
dc.subject.keyword | CHUVI | |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | |
dc.typesophos | Artículo Original | |
dc.volume.number | 12 |
Ficheiros no ítem
Este ítem aparece na(s) seguinte(s) colección(s)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)
